Organogenesis Holdings Inc. (NASDAQ: ORGO)
$3.1300
N/A ( 0% ) 1.0M
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced wound care, surgical and sports medicine markets. Its product category includes Advanced Wound Care and Surgical and Sports Medicine. It has single operating segment which has regenerative medicine. The company generates maximum revenue from Advanced Wound Care products. Some of its products include PuraPly Antimicrobial, Affinity, NuShield, Apligraf, Dermagraft and others.
Market Data
Open
$3.1300
Previous close
$3.1300
Volume
1.0M
Market cap
$393.52M
Day range
$3.0310 - $3.1490
52 week range
$2.1650 - $4.5700
SEC Filings
| Form Type | Description | Pages | Date |
|---|---|---|---|
| 4 | Insider transactions | 1 | Nov 14, 2024 |
| 8-k | 8K-related | 18 | Nov 13, 2024 |
| 10-q | Quarterly Reports | 81 | Nov 12, 2024 |
| 8-k | 8K-related | 13 | Nov 12, 2024 |
| 10-q | Quarterly Reports | 84 | Aug 08, 2024 |
| 8-k | 8K-related | 13 | Aug 08, 2024 |
| 4 | Insider transactions | 1 | Jul 18, 2024 |
| 8-k | 8K-related | 14 | Jun 21, 2024 |
| 10-q | Quarterly Reports | 80 | May 09, 2024 |
| 8-k | 8K-related | 13 | May 09, 2024 |